Editorial
 DRUG BAN POLICY   
 Wednesday, December 04, 2013 
 A leading financial daily reported last week that the Union health ministry is considering to disallow marketing of drugs in India which are already banned in two or more countries on grounds of efficacy and safety. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]Sanofi announces positive results from phase IIIb study of Lyxumia
17:45  [IST]India Med Expo 2013 begins in Hyderabad
17:00  [IST]Immunomedics' SCLC therapy drug, IMMU-132 receives US orphan drug designation
16:00  [IST]GSK's Synflorix gets EU marketing authorisation for additional pneumonia indication
15:45  [IST]Union govt plans to set benchmarks in cost of treatments to make healthcare affordable
15:35  [IST]Vodafone Foundation's book on ‘Women of Pure Wonder’, chronicles 60 Indians including Biocon chief
more news >>
TOP NEWS
08:00  [IST]Doctors seek PM’s intervention to pass pending NDPS Bill
08:00  [IST]IPA asks PCI to initiate measures for preparation of Central Register of Pharmacists
08:00  [IST]Govt to take action against violators based on their explanation and reports: Pondicherry health secretary
08:00  [IST]Centre chips in Rs.100 crore to set up first ever Nano Park in Karnataka
08:00  [IST]NPPA fixes prices of 18 more formulations
08:00  [IST]Hearing on case against new pharma policy to come up only in January, under new bench
more news >>
YESTERDAY'S NEWS
18:00  [IST]Ambit Bio announces regulatory update following US FDA meeting regarding quizartinib
17:00  [IST]Great Lakes receives US patent for sensor based continuous Parkinson's assessment during daily activities
16:15  [IST]Researchers develop advanced 'PharmaCheck' technology to check substandard drugs
16:00  [IST]Microtest Labs offers OECD FET testing
15:30  [IST]IFPMA and Global Fund collaborate to help protect patients from fake medicines
15:00  [IST]Eclipse Aesthetics introduces new Turbo Safety Needle for Eclipse MicroPen
more news >>
INTERVIEW  
South America an important market for Indian bio-pharma in future
Ajay Bharadwaj.jpgAjay Bharadwaj, CEO, Anthem Biosciences
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the newly introduced audio-visual recording of informed consent bring the much needed transparency in clinical trials in India?
  
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2010 Saffron Media Pvt. Ltd |